|
Age (years) (μ, SD)
|
58.8 ± 8.0
|
|
Men, n (%)
|
892 (85.0%)
|
|
CYP2C19C*2 allele frequency
| |
|
- AA
|
27 (2.6%)
|
|
- AG
|
279 (26.6%)
|
|
- GG
|
744 (70.9%)
|
|
History of myocardial infarction, n (%)
|
611 (58.2%)
|
|
History of heart failure, n (%)
|
128 (12.6%)
|
|
Clinical score (angiographic evaluation)
| |
|
- 1 vessel disease
|
255 (24.3%)
|
|
- 2 vessel disease
|
279 (26.6%)
|
|
- 3 vessel disease
|
449 (42.8%)
|
|
- unknown
|
52 (5.0%)
|
|
School education <10 yrs., n (%)
|
625 (59.5%)
|
|
Body mass index (kg/m2), (μ, SD)
|
27.1 ± 3.5
|
|
History of diabetes, n (%)
|
184 (17.7%)
|
|
Total cholesterol (mg/dl) (μ, SD)
|
168.9 (32.6)
|
|
LDL-cholesterol (mg/dl) (μ, SD)
|
100.4 (28.9)
|
|
HDL-cholesterol (mg/dl) (μ, SD)
|
39.4 (10.5)
|
|
C-reactive protein (mg/L) *
|
3.47 (1.23; 8.37)
|
|
Creatinine Clearance (mL/min) *
|
93.75 (78.20; 115.00)
|
|
Cystatin C (mg/L)*
|
1.03 (0.93; 1.19)
|
|
NT-proBNP (pg/mL)*
|
572.00 (279.90; 1101.00)
|
|
GRACE Score (points) (μ, SD)
|
95.9 (20.8)
|
